Senté, Inc. announces that it has closed its Series-B financing, raising $2.1 million from a combination of new and existing biotechnology investors. Proceeds from the financing will help Senté, Inc. expand commercial operations, scale development capabilities, and add additional line extensions to its portfolio of differentiated medical grade skin care products.